COVID-19
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who have been diagnosed as COVID-19 according to The Diagnosis and Treatment Plan for 2019-nCoV(The Fifth Trial Edition); 2. aged between 18 to 80 years old, male or female; 3. the subjects participating the clinical trial are voluntary and sign the informed consent, thoroughly informed the purpose, method, possible reaction.
Exclusion criteria
Exclusion criteria: 1. Patients who are difficult to be administered orally or by nasal feeding, those who are allergic to the test drug and those who are intolerant to the drug; 2. The compliance of medication cannot be guaranteed during the treatment 3. Patients with severe primary respiratory diseases, or pneumonia caused by other pathogen. 4. Patients with serious diseases, malignant tumors or mental diseases; 5. Pregnant women, urine pregnancy test positive; 6. Participated in other drug trials in the past month; 7. The investigator judged that the patient was not suitable for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| syndrome;nucleic acid of nCoV-19; | — |
Secondary
| Measure | Time frame |
|---|---|
| blood count;liver and kidney function;cardiac enzymes;lung CT; | — |
Countries
China
Contacts
Guangzhou Eighth People's Hospital